BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sun LQ, Peng LS, Guo JF, Jiang F, Cui F, Huang HJ, Jin ZD. Validation of serum tumor biomarkers in predicting advanced cystic mucinous neoplasm of the pancreas. World J Gastroenterol 2021; 27(6): 501-512 [PMID: 33642824 DOI: 10.3748/wjg.v27.i6.501] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Keefe D, Smith R, Gao B, Malkawi WL, Geary SM, Kasi PM, Sharif S, Salem AK, Toor F. Colorectal Cancer Biosensor Using Vertically-Oriented Silicon Nanowires. 2022 IEEE Sensors 2022. [DOI: 10.1109/sensors52175.2022.9967069] [Reference Citation Analysis]
2 Caban M, Małecka-wojciesko E. Pancreatic Incidentaloma. JCM 2022;11:4648. [DOI: 10.3390/jcm11164648] [Reference Citation Analysis]
3 Liu J, Xing Y, Sun L. Commentary: The Tumor Markers and Blood Inflammation Markers Are More Likely to Be the Indicators for Differentiating Benign and Malignant Pancreatic Mucinous Cystic Neoplasms. Front Oncol 2022;12:901010. [PMID: 35720014 DOI: 10.3389/fonc.2022.901010] [Reference Citation Analysis]
4 Zhao T, Mao G, Chen M. The Role of Change Rates of CYFRA21-1 and CEA in Predicting Chemotherapy Efficacy for Non-Small-Cell Lung Cancer. Comput Math Methods Med 2021;2021:1951364. [PMID: 34603482 DOI: 10.1155/2021/1951364] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]